Sam Altman’s New Brain Venture, Merge Labs, Will Spin Out of a Nonprofit
The Rise of Brain-Computer Interfaces: Sam Altman's New Venture, Merge Labs
The concept of humans merging with machines has long been a staple of science fiction, but it's becoming increasingly clear that this vision is not only possible but also rapidly approaching. At the forefront of this technological revolution is Sam Altman, the CEO of OpenAI, who has recently announced the launch of a new brain-computer interface (BCI) startup called Merge Labs. But what exactly is Merge Labs, and how does it fit into the broader landscape of BCI research?
The Birth of Merge Labs
Merge Labs is being spun out of the Los Angeles-based nonprofit Forest Neurotech, which has been working on an ultrasound-based BCI for the past few years. The nonprofit was launched in 2023 out of the philanthropic incubator Convergent Research, which is funded in part by former Google CEO Eric Schmidt, his wife Wendy Schmidt, and billionaire hedge fund manager Ken Griffin. Forest Neurotech's CEO, Sumner Norman, and chief scientific officer, Tyson Aflalo, are among the cofounders of Merge Labs, along with Alex Blania, the CEO of World, an Altman-backed digital identity company.
The Technology Behind Merge Labs
Merge Labs will focus on using ultrasound to read brain activity, a technology that has been developed by Forest Neurotech. Unlike implants like Neuralink's, which measure electrical activity directly from neurons, Forest's device interprets brain activity indirectly by using ultrasound to detect changes in blood flow. Active regions of the brain have more blood flow, and by detecting these changes, the device can infer brain activity. This approach may provide some advantages over traditional BCI methods, including the potential for whole-brain access and the ability to provide stimulation with focused sound waves.
The Potential of Ultrasound-Based BCIs
An ultrasound-based BCI could enable more personalized neurological treatments and highly sophisticated assistive or augmentation capabilities. For example, it could be used to treat mental health disorders and brain injury, or to provide assistive technologies for individuals with paralysis or other motor disorders. The device is also being trialed in an early safety study in the UK, supported by the country's Advanced Research and Invention Agency.
The Future of Brain-Computer Interfaces
The development of BCI technology is rapidly advancing, with several startups and research institutions working on various approaches. While Merge Labs is focused on ultrasound-based BCIs, other companies like Neuralink are developing implantable devices that measure electrical activity directly from neurons. The potential applications of BCI technology are vast, and it's likely that we will see significant advancements in the coming years.
Implications and Real-World Applications
The development of BCI technology has significant implications for various fields, including healthcare, education, and technology. For example, BCI technology could be used to create new assistive technologies for individuals with disabilities, or to provide new treatments for neurological disorders. It could also be used to enhance human cognition and performance, or to create new forms of entertainment and art.
Forward-Looking Thoughts
As we move forward in the development of BCI technology, it's essential to consider the potential risks and challenges associated with this technology. For example, there are concerns about the potential for BCI technology to be used for malicious purposes, such as hacking or surveillance. Additionally, there are questions about the ethics of using BCI technology to enhance human cognition and performance. As we continue to advance in this field, it's essential to prioritize responsible development and deployment of BCI technology.
Conclusion
The development of BCI technology is rapidly advancing, with several startups and research institutions working on various approaches. Merge Labs, a new brain-computer interface startup founded by Sam Altman, is focused on using ultrasound to read brain activity. This technology has the potential to provide whole-brain access and to enable more personalized neurological treatments and highly sophisticated assistive or augmentation capabilities. As we move forward in the development of BCI technology, it's essential to consider the potential risks and challenges associated with this technology and to prioritize responsible development and deployment.
